
Augmedix Revolutionizes Medical Documentation with Augmedix Go
Augmedix Go is the culmination of a collaboration between Augmedix and HCA Healthcare
Generative AI refers to artificial intelligence models that generates content, like text, images, music or any media by learning from datasets. Unlike traditional artificial intelligence which analyses or classifies data, GenAI tools can produce outputs, with realistic images, coherent text, unique music compositions or video creation. These models, including GPT for text and DALL-E for images, Sora for Video creation are transforming content creation. They’re significant for chief digital or CDO’s, enabling enhanced data interaction, creative problem-solving, and automated content generation.
Augmedix Go is the culmination of a collaboration between Augmedix and HCA Healthcare
Both our companies have shared values and are research-driven organizations pushing the boundaries of technology
This is a watershed moment for Snowflake, with our AI research team innovating at the
Lenovo is working to accelerate insights from data by delivering new AI solutions for use
Our vision is for every legal professional worldwide to have a virtual AI Assistant that
As SightX evolves, the vision for Ada is not just about incorporating cutting-edge capabilities but
DeFi Lens stands at the forefront of market intelligence, seamlessly blending popular analytics tools in
This groundbreaking development represents a major advancement in insurance technology, set to transform the way
Our goal with Fine-Tune Studio is to empower our clients to navigate the evolving landscape
Their collaboration aims to make Microsoft’s generative AI and Copilots accessible to a wide range
A Vendor Briefing is a research tool for our industry analysts, and an opportunity for a vendor to present its products, services and business strategies to analysts who cover the vendor specifically or a related technology or market.
AIM Research encourages technology vendors and agencies to brief our team for PeMa Quadrants, when introducing a new product, changing a business model, or forming a partnership, merger, or acquisition.